Effect of periodontal therapy with systemic antimicrobials on parameters of metabolic syndrome: A randomized clinical trial

S. Bizzarro, U. van der Velden, W.J. Teeuw, V.E.A. Gerdes, B.G. Loos

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Aim: To investigate the effect of basic periodontal therapy (BPT) with antimicrobials (AM) on the parameters of metabolic syndrome (MetS) (waist circumference, systolic/diastolic blood pressure [BP], HDL- cholesterol, triglycerides, glucose).

Methods: One hundred and ten periodontitis patients without known comorbidities and unaware of possible MetS were randomly assigned to BPT (n = 56) or BPT+AM (n = 54) and followed for 12 months post-therapy. Number of patients with undiagnosed MetS was also determined.

Results: In all patients, the periodontal condition improved; however, the BTP+AM group showed greater pocket depth reduction than the BPT group. Post-therapy, sys-tolic BP (p < .05) and triglycerides (p < .05) reduced significantly during the follow-up period. No significant differences could be assessed between the BPT+AM and BPT group. Despite the absence of self reported comorbidities, 27.2% (n = 30) periodontitis patients fulfilled the criteria of MetS at baseline. After therapy, this proportion changed to 14.5% at 3 months (p = .007), to 17.3% at 6 months (p = .017) and to 21.8% at 12-month follow- up (p = .383).

Conclusion: Although a reduction in systolic BP and triglycerides and a temporarily improvement in the whole metabolic status were observed, the use of antimicrobials in conjunction with BTP does not yield any additional improvement in the parameters of MetS.

Original languageEnglish
Pages (from-to)833-841
Number of pages9
JournalJournal of Clinical Periodontology
Volume44
Issue number8
DOIs
Publication statusPublished - Aug 2017

Bibliographical note

Clinical trial registration number: ISRCTN36043780

Funding

Funding information This study was funded by several sources: by the authors' institution, by an unconditional grant from Philips Oral Healthcare, by a grant from the University of Amsterdam for the focal point “Oral Infection and Inflammation” and by a grant from the Dutch Society of Periodontology (NVvP). Clinical trial registration number: ISRCTN36043780 (Current Controlled Trials)

FundersFunder number
Dutch Society of Periodontology
NVVPISRCTN36043780
Philips Oral Healthcare
Universiteit van Amsterdam

    Fingerprint

    Dive into the research topics of 'Effect of periodontal therapy with systemic antimicrobials on parameters of metabolic syndrome: A randomized clinical trial'. Together they form a unique fingerprint.

    Cite this